Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04047446 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine vs Dexamethasone ISB
A Phase 4 study of Shoulder Pain, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT04047446: Completed Phase 4 study of Shoulder Pain, sponsored by Hospital for Special Surgery, New York.
NCT04047446 is a Phase 4 study of Shoulder Pain that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 112 participants, above the 97-participant average among 27 other Shoulder Pain trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04047446, a Phase 4 study of Shoulder Pain, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, patients receiving shoulder arthroscopy will receive an interscalene block for pain management containing either liposomal bupivacaine and standard bupivacaine or standard bupivacaine and dexamethasone. Patients will be followed up with to determine postoperative pain and block duration.
Primary Outcome
NRS pain at rest averaged over the first 72 hours. NRS pain is on a scale from 0 (no pain at all) to 10 (worst pain imaginable). Patient reported pain at 24, 48, and 72 hours are averaged to produce this number. Lower score is a better outcome.
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Exparel 133 MG Per 10 ML Injection
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2019-07-11 |
| Est. Completion | 2021-03-19 |
| Phase | Phase 4 |
What the finished NCT04047446 record still lists
NCT04047446 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, above the 97-participant average among 27 other Shoulder Pain trials with a reported enrollment target (15% higher).
The record links to 1 condition, with Shoulder Pain appearing as the primary indexed condition, and to 2 interventions - of which Dexamethasone is the first listed.
NCT04047446 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04047446 about?
NCT04047446 is a clinical study titled "Liposomal Bupivacaine vs Dexamethasone ISB". In this study, patients receiving shoulder arthroscopy will receive an interscalene block for pain management containing either liposomal bupivacaine and standard bupivacaine or standard bupivacaine and dexamethasone. Patients will be followed up with to determine postoperative pain and block durati...
What is the current status of trial NCT04047446?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2019-07-11. Estimated completion is 2021-03-19.
What conditions does trial NCT04047446 study?
This clinical trial studies the following conditions: Shoulder Pain.
What interventions are being tested in trial NCT04047446?
The interventions under investigation include: Dexamethasone (DRUG), Exparel 133 MG Per 10 ML Injection (DRUG).
Who is sponsoring clinical trial NCT04047446?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04047446 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shoulder Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04047446's enrollment target sits among peer trials
112 8th of 27 higher than 20 of 27 other Shoulder Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Connective Tissue Matrix for Rotator Cuff Tendinopathy
ACTIVE NOT RECRUITING · Phase 4
-
Opioid-Free Pain Protocol After Shoulder Arthroplasty
ACTIVE NOT RECRUITING · Phase 4
-
Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair
COMPLETED · Phase 4
-
Shoulder RFA Pilot Study
RECRUITING
-
MDR - Comprehensive Primary Revision Stems PMCF
RECRUITING
-
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI